News        Sectors        Watchlists

Celldex Therapeutics Inc. (CLDX)

CLDX stock forecast: buy or sell

Close on Sep 28th, 2020
$14.98 0.17%
3 months performance
0.20%
Published: September 29th, 2020 - 5.37am EDT

CLDX stock outlook

  • Celldex Therapeutics closed yesterday at $14.98 after skyrocketing a 17.03% and broke a streak of 4 sessions in green.
  • Yesterday, it broke out above $13.49, a resistance not crossed since late July.
  • The price is currently over the upper Bollinger band, which often indicates a short-term correction
  • Yesterday broke out above its latest top at $12.82
  • Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of immunotherapies and other cancer-targeting biologics.

Important:
The comments given in this post are personal and not recommendations for you to buy or sell stocks. The author of this paper does not have an understanding of the individual circumstances of the reader, his or her own financial statements or his or her own best interests at any given time. All users should speak with their financial advisor before buying or selling any securities Opinions are provided for general educational reasons only

CLDX stock charts

Should I buy Celldex Therapeutics stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best

Is CLDX stock a buy?

Currently, Celldex Therapeutics stock doesn't match any of these trading strategies, so our recommendation is not to buy now. This doesn't mean we expect a selloff for CLDX in the next few days, or that it may not rise higher. Simply, it doesn't match our recommended trading systems

Should I sell Celldex Therapeutics stock?

"To sell or not to sell", if you are holding Celldex Therapeutics shares?. As when we have to buy shares, choosing when is the best time to sell is not a whimsy decision, and we must use our own trading strategy. When selling, as well as buying, detailed strategies are very easy to use but are only applicable for selling shares in your porfolio, not for shorting Celldex Therapeutics stock

A guiding principle is that you must never mantain an open trade that results in higher than expected losses at the time of purchase. The moment to sell your stock must always be dictated by the stop-loss (automatic or manual)

Is it time to sell Celldex Therapeutics stock?

In the current situation of Celldex Therapeutics there is not any eligible sell setup, so Celldex Therapeutics stock holders with operations in profit can keep their positions

Analysts' recommendations to buy or sell Celldex Therapeutics stock

Brokerage firms and financial institutions post stock ratings based on their views of the market and the fundamental and technical situation of the analyzed stock. Unfortunately, the accuracy of these predictions is not very high, and certainly not a direct buy or sell signal

In the previous 30 days we couldn't find any rating for Celldex Therapeutics

Technical analysis

SMAs overview

A favorite tool of many traders are the moving averages, that easily show trend direction. A moving average is calculated as the simple mean of the previous N periods (usually sessions). Usual time periods used for moving averages are 21 days, 50 days, 100 days and 200 days

CLDX SMAs chart

Supports and resistances

Technical analysts use support and resistance levels to find price points in the stock price action that tend to act as obstacles, containing the price of an asset to move up or down. Supports are levels where the price may stop as it falls. Price is more likely to "bounce off" this level rather than break through it. Nevertheless, if the price breaks down the support, it is likely to continue declining until finding another support level. On the other side, a resistance level is where the price tends to find opposition as it rises. In the same manner, the price is more liable to "bounce off" at this level, and if it finally breaches this level, the price will rally easily until it approaches the next resistance

The current resistance levels are:

  • R1: $30.75 (105.27% above)
  • R2: $33.00 (120.29% above)
  • R3: $33.45 (123.3% above)
  • The current supports are:

  • S1: $13.91 (-7.14% below)
  • S2: $13.49 (-9.95% below)
  • S3: $12.82 (-14.42% below)
  • Bollinger bands

    The so-called Bollinger bands are a widely known technical strategy created by John Bollinger. It is made up of 3 bands that are outlined superimposed on the price evolution chart:

    • The central band is a moving average, usually a simple moving average calculated with 20 periods
    • The upper band is calculated by adding to the value of the simple moving average 2 times the standard deviation of the moving average
    • The lower band is calculated by subtracting from the simple moving average 2 times the standard deviation of the moving average

    When the price moves out of the band (above the upper line or below the lower line) it means that the price action is maintaining a very strong momentum and therefore can reverse the trend to the average. At this point, the price is over the upper band, which should mean a possible short-term corrective movement (at least) until it is under the band

    CLDX RSI chart

    Relative strength index

    The RSI (Relative Strength Index) is an oscillator-type indicator that measures price movements to identify when the share or financial asset is oversold or overbought. Like other oscillation indicators, the RSI moves in a range from 0 to 100. The relative strength indicator is one of the best known and most widely used indicators, and it was invented by J. Welles Wilder in the late 1970s

    The RSI has been between the the levels of 30 and 70 for several weeks, and therefore, without this indicator really serving to help us make any decisions.

    CLDX RSI chart

    Earnings and financials

    Celldex Therapeutics Inc. (CLDX) released quarterly earnings of $-0.50 per share, upping the Market consensus estimate of $-0.58 per share. This quarterly report represents an earnings surprise of 13.79%. On the contrary, reported sales were $2,360,000, aligned with analysts' forecasts.

    Same quarter one year ago, reported EPS was $-0.84, so current EPS is a gain of 40.48%. Looking at sales, figures collapsed a -66.99% compared to $7,150,000 same quarter a year ago.

    CLDX posts Q3 financial report on mid next November. Forecasted per-share earnings of %s for this quarter is $-0.36. Earnings reporting day has a more than usual risk for investors as the results provided can jump up or down the shares price with very low volume and not honouring your buy or stop-loss orders. You can find more details about the earnings conference call and the financial reports on the Investor Relations section of its website: http://www.celldex.com.

    CLDX revenues and profits chart